· Form D filing · Baseline
Reported sold as filed: $3,699,998 · Offering amount as filed: $3,699,998
SEC source checked 29 Oct 2026. This is the issuer’s historical filing, not a current valuation.
View original evidence ↗PreciseDx, Inc.
On its website, the company describes its work as “PreciseBreast® uses OncoIntelligence TM , our proprietary AI-platform, to combine AI-grade with key clinical factors to produce an OncoIntelligence Score TM . PreciseBreast®, clinically…”.
- Industry
- Other Health Care
- Tracked VC backers
- 0
- Location
- Not recorded
Publicly documented VC backing
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
No tracked VC backing is recorded.